Evidence map›Paper›PMID 34754676›Full record

ReviewCureus2021

Role of Vitamin B12 and Folate in Metabolic Syndrome.

Tejaswini Ashok, Harivarsha Puttam, Victoria Clarice A Tarnate, Sharan Jhaveri, Chaithanya Avanthika, Amanda Guadalupe Trejo Treviño, Sandeep Sl, Nazia T Ahmed

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Tejaswini AshokInternal Medicine, Jagadguru Sri Shivarathreeshwara Medical College, Mysore, IND.
Harivarsha PuttamInternal Medicine, Employees' State Insurance Corporation Medical College and Hospital, Hyderabad, IND.
Victoria Clarice A TarnateMedicine, Far Eastern University - Nicanor Reyes Medical Foundation, Quezon City, PHL.
Sharan JhaveriInternal Medicine, Smt. Nathiba Hargovandas Lakhmichand Municipal Medical College, Ahmedabad, IND.
Chaithanya AvanthikaMedicine and Surgery, Karnataka Institute of Medical Sciences, Hubli, IND.
Amanda Guadalupe Trejo TreviñoMedicine, Facultad de Medicina Universidad Autonoma de Nuevo León, Monterrey, MEX.
Sandeep SlInternal Medicine, SRM Medical College Hospital & Research Centre, Kattankulathur, IND.
Nazia T AhmedMedicine, Shahabuddin Medical College and Hospital, Dhaka, BGD.
Far Eastern University · THEmployees' State Insurance Model Hospital · INEmployees State Insurance Post Graduate Institute of Medical Sciences and Research · INJSS Dental College and Hospital · INSmt. N.H.L. Municipal Medical College · INSRM Institute of Science and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MS) is a collection of pathological metabolic conditions that includes insulin resistance, central or abdominal obesity, dyslipidemia, and hypertension. It affects large populations worldwide, and its prevalence is rising exponentially. There is no specific mechanism that leads to the development of MS. Proposed hypotheses range from visceral adiposity being a key factor to an increase in very-low-density lipoprotein and fatty acid synthesis as the primary cause of MS. Numerous pharmaceutical therapies are widely available in the market for the treatment of the individual components of MS. The relationship between MS and vitamin B complex supplementation, specifically folic acid and vitamin B12, has been a subject of investigation worldwide, with several trials reporting a positive impact with vitamin supplementation on MS. In this study, an all-language literature search was conducted on Medline, Cochrane, Embase, and Google Scholar till September 2021. The following search strings and Medical Subject Headings (MeSH) terms were used: "Vitamin B12," "Folate," "Metabolic Syndrome," and "Insulin Resistance." We explored the literature on MS for its epidemiology, pathophysiology, newer treatment options, with a special focus on the effectiveness of supplementation with vitamins B9 and B12. According to the literature, vitamin B12 and folate supplementation, along with a host of novel therapies, has a considerable positive impact on MS. These findings must be kept in mind while designing newer treatment protocols in the future.

Indexed as

cardiovascular diseasediabetes and metabolic syndromefolic acid supplementationinsulin resistancenutrition and metabolismobesity and diabetesvitamin b12 supplementationvitamin b supplementation

Identifiers

PMID34754676
PMCPMC8569690
OpenAlexW3203578256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.